- 1) McKenzie, D., Malone, S., Kushner, S., Oleson, J. J., and Subbarow, Y., The effect of nicotinic acid on experimental tuberculosis of white mice. J. Lab. Clin. Med., 33, 1249-1253 (1948).
- 2) World Health Organization, WHO report on the tuberculosis epidemic; stop TB at the source. Tuberculosis Program, World Health Organization, Geneva, Switzerland, 1995.
- 3) Konno, K., Feldmann, F. M., and McDermott, W., Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis., 95, 461-469 (1967).
- 4) Trivedi, S. S. and Desai, S. G., Pyrazinamidase activity of Mycobacterium tuberculosis-a test sensitivity to pyrazinamide. Tubercle, 68, 221-224 (1987).
- 5) Scorpio, A. and Zhang, Y., Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med., 2, 662-667 (1996).
- 6) Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., and Zhang, Y., Characterization of pncA mutations in pyrazinamide-resistant Mycobacterirum tuberculosis. Antimicrob. Agents Chemother., 41, 540-543 (1997).
- 7) McCune, R. M., Tompsett, R., and McDermott, W., The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. J. Exp. Med., 104, 763-802 (1956).
- 8) Tarshis, M. S. and Weed, W. A., Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three solid media. Am. Rev. Tuberc., 67, 391-395 (1953).
- 9) Shibata, K., Effects of dietary pyrazinamide on the growth of weaning rats fed with a nicotinic acid-free and tryptophan-limited diet. Agric. Biol. Chem., 55, 3111-3112 (1991).
- 10) Shibata, K., Effects of pyrazinamide on tryptophan-niacin conversion in rats. Agric. Biol. Chem., 54, 2463-2464 (1990).
- 12) Hayakawa, T., Shibata, K., and Iwai, K., Purification and some properties of nicotinate phosphoribosyltransferase from hog liver. Agric. Biol. Chem., 48, 445-453 (1984).
- 13) Nasu. S., Yamaguchi, K., Sakakibara, S., Imai, H., and Ueda, I., The effect of pyrazines on the metabolism of tryptophan and nicotinamide adenine dinucleotide in the rat. Evidence of the formation of a potent inhibitor of aminocarboxymuconate-semialdehyde decarboxylase from pyrazinamide. Biochim. Biophys. Acta, 677, 109-119 (1981).
- 14) Pullman, M. E. and Colowick, S. P., Preparation of 2- and 6-pyridones of N1-methylnicotinamide. J. Biol. Chem., 206, 121-127 (1954).
- 15) Shibata, K., Kawada, T., and Iwai, K., Simultaneous micro-determination of nicotinamide and its major metabolites, N1-methyl-2-pyridone-5-carboxamide and N1-methyl-3-pyridone-4-carboxamide, by high-performance liquid chromatography. J. Chromatogr., 424, 23-28 (1988).
- 16) Shibata, K. and Murata, K., Blood NAD as an index of niacin nutrition. Nutr. Int., 2, 177-181 (1986).
- 17) Shibata, K., The metabolism of niacin in each organ and the biological method for assessing the nutritional status of niacin in the rat. Vitamins (Japan), 61, 39-56 (1987).
- 18) Shibata, K. and Tanaka, K., Simple measurement of blood NADP and blood levels of NAD and NADP in humans. Agric. Biol. Chem., 50, 2941-2942 (1986).
- 19) Shibata, K., Ultramicro-determination of N1-methylnicotinamide in urine by high-performance liquid chromatography. Vitamins, 61, 599-604 (1987).
- 20) Shibata, K., Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography. J. Chromatogr., 430, 376-380 (1988).
- 21) Shibata, K. and Onodera, M., Simultaneous high-performance liquid chromatographic measurement of xanthurenic acid and 3-hydroxyanthranilic acid in urine. Biosci. Biotechnol. Biochem., 56, 974 (1992).
- 22) Ichiyama, A., Nakamura, S., Kawai, H., Honjo, T., Nishizuka, Y., Hayaishi, O., and Senoh, T., Studies on the benzene ring of tryptophan in mammalian tissues. II. Enzymic formation of α-aminomuconic acid from 3-hydroxyanthranilic acid. J. Biol. Chem., 240, 740-749 (1965).
- 23) Shibata, K., Fukuwatari, T., and Sugimoto, E., Reversed phase HPLC of nicotinic acid mononucleotide for measurement of quinolinate phosphoribosyltransferase. J. Chromatogr., 749, 281-285 (2000).
- 24) Shibata, K. and Matsuo, H., Changes in blood NAD and NADP levels, and the urinary excretion of nicotinamide and its metabolites in women students after nicotinamide administration. Vitamins (Japan), 64, 301-306 (1989).
- 25) Ikeda, M., Tsuji, H., Nakamura, S., Ichiyama, A., Nishizuka, Y., and Hayaishi, O., Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals. J. Biol. Chem., 240, 1395-1401 (1965).
- 26) Hayaishi, O., Studies on the biosynthesis of NAD from tryptophan. Vitamins (Japan), 31, 107-114 (1965).
- 27) Ghafoorunissa and Rao, B. S., Effect of protein level in the diet on quinolinate phosphoribosyltransferase of rat liver. Life Sci., 15, 1597-1602 (1974).
- 28) Sanada, H., Alteration of tryptophan-niacin metabolism by hormones and nutrients. Vitamins (Japan), 61, 549-562 (1987).
- 29) Shibata, K. and Toda, S., Effect of thyroxine on the conversion ratio of tryptophan to nicotinamide in rats. Biosci. Biotechnol. Biochem., 58, 1757-1762 (1994).
- 30) Shibata, K., Effects of protein-amino acids, lipid, and carbohydrate on the conversion ratio of tryptophan to niacin. Vitamins (Japan), 70, 369-382 (1996).
- 32) Shin, M., Iwamoto, N., Yamashita, M., Sano, K., and Umezawa, C., Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets. Biochem. Pharmacol., 55, 367-371 (1998).
- 33) Zimhony, O., Cox, J. S., Welch, J. T., Vilcheze, C., and Jacobs, W. R., Jr., Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Nat. Med., 6, 1043-1047 (2000).
- 34) Bloch, K., Fatty acid synthases from Mycobacterium phlei. Methods Enzymol., 35, 84-90 (1975).
- 35) Brennan, P. J. and Nikaido, H., The envelope of mycobacteria. Annu. Rev. Biochem., 64, 29-63 (1995).
- 36) Vesell, E. S. and Beyer, K. H., Jr., Studies on pyrazinoylguanidine. 7. Effects of single oral doses in normal human subjects. Pharmacology, 58, 140-146 (1999).
- 11) Shibata, K., Fukuwatari, T., and Sugimoto, E., Effects of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and of tryptophan to serotonin in rats. Biosci. Biotechnol. Biochem., 65, 1339-1346 (2001).
- 31) Fukuwatari, T., Morikawa, Y., Hayakawa, F., Sugimoto, E., and Shibata K., Influence of adenine-induced renal failure on tryptophan-niacin metabolism in rats. Biosci. Biotechnol. Biochem., 65, 2154-2161 (2001).
Full access
Growth-promoting Activity of Pyrazinoic Acid, a Putative Active Compound of Antituberculosis Drug Pyrazinamide, in Niacin-deficient Rats through the Inhibition of ACMSD Activity
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.